Physician profile
Jason K Maclaughlin
NPI 1235134313
$10,226.23
in general payments reported to CMS, 2019-2025
20 companies · $1,453 in 2025
The $1,453 reported for 2025 was more than what 95% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,859 · 2020: $803 · 2021: $1,352 · 2022: $2,457 · 2023: $1,064 · 2024: $1,238 · 2025: $1,453.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,755.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,755.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $3,835.02 | 2019-2025 | Total30, Precision7, Eysuvis |
| Bausch & Lomb Americas INC. | $1,371.60 | 2022-2025 | Infuse, Xiidra, Miebo |
| Johnson & Johnson Vision Care, INC. | $1,197.37 | 2020-2025 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $580.18 | 2019-2021 | |
| Optos, INC. | $545.13 | 2019 | |
| Kala Pharmaceuticals, INC. | $502.13 | 2020-2022 | |
| Sun Pharmaceutical Industries INC. | $439.82 | 2019-2025 | Cequa, Xelpros |
| Sight Sciences, INC. | $408.20 | 2019-2022 | |
| Biotissue Holdings INC. | $338.74 | 2020-2023 | |
| Oyster Point Pharma, INC. | $184.10 | 2022-2024 | Tyrvaya |
| Abbvie INC. | $169.65 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $161.53 | 2020-2021 | |
| Allergan, INC. | $139.51 | 2022 | |
| Glaukos Corporation | $122.40 | 2025 | Idosetr |
| Tarsus Pharmaceuticals, INC. | $83.21 | 2024-2025 | Xdemvy |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $79.38 | 2019 | |
| Shire North American Group INC | $21.19 | 2019 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Maculogix, INC. | $14.30 | 2020 | |
| Abb Con-Cise Optical Group LLC | $13.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Maclaughlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.